Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Ramses Forsyth actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
OZR4465: Het ontcijferen van cellulaire landschappen in gezond en ziek weefsel: uitbouw van de Spatial Proteomics And Transcriptomics Alliance (SPArTA)
Rooman, I. (Administrative Promotor), De Leu, N. (CoI (Co-Promotor)), Forsyth, R. (CoI (Co-Promotor)), Janssen, T. (CoI (Co-Promotor)), Staels, W. (CoI (Co-Promotor)), Waelput, W. (CoI (Co-Promotor)) & Van Laere, S. (CoI (Co-Promotor))
1/05/26 → 30/04/30
Project: Fundamenteel
-
IRP27: TumorScope: Digitaal gezondheidsonderzoek rond data, AI en wettelijke uitdagingen aan de VUB en het UZB
Vranken, W. (Administrative Promotor), Vandemeulebroucke, J. (CoI (Co-Promotor)), Cornu, P. (CoI (Co-Promotor)), Quinn, P. (CoI (Co-Promotor)), Van Dooren, S. (CoI (Co-Promotor)), Duerinck, J. (CoI (Co-Promotor)), Olsen, C. (CoI (Co-Promotor)) & Forsyth, R. (CoI (Co-Promotor))
1/11/24 → 30/04/27
Project: Fundamenteel
-
VLAOO27: NextGen Digital Pathology
Forsyth, R. (Administrative Promotor)
1/09/22 → 28/02/25
Project: Toegepast
-
OZR3588: Financiering FWO Hercules: ERA platform: Uitgebreid RNA Analyse platform - versie 2.0
Rooman, I. (Administrative Promotor), Bouwens, L. (Co-Promoter), Heimberg, H. (Co-Promoter), Neyns, B. (Co-Promoter), Vranken, W. (Co-Promoter), Vanhaecke, T. (Co-Promoter), Massie, A. (Co-Promoter), van Grunsven, L. (Co-Promoter), De Bruyne, E. (Co-Promoter), De Bundel, D. (Co-Promoter), Forsyth, R. (Co-Promoter), Breckpot, K. (Co-Promoter), Van Dooren, S. (Co-Promoter), De Kock, J. (Co-Promoter), Njemini, R. (Co-Promoter) & Laoui, D. (Co-Promoter)
1/05/20 → 30/04/24
Project: Fundamenteel
-
IRP20: TumorScope: VUB en UZ Brussel expertise als hefboom naar een onderzoeksplatform voor digitale gezondheid.
Vranken, W. (Administrative Promotor), Vandemeulebroucke, J. (Co-Promoter), Cornu, P. (Co-Promoter), Forsyth, R. (Co-Promoter), Quinn, P. (Co-Promoter), Van Dooren, S. (Co-Promoter) & Duerinck, J. (Co-Promoter)
1/11/19 → 30/09/25
Project: Fundamenteel
-
Immune Cell Infiltration in Primary and Recurrent Glioblastoma, IDH-Wild Type: Validation of an Immunohistochemistry-Based Scoring System for Research and Clinical Practice
Verlinden, L., Michotte, A., Cools, W., Locy, H., Forsyth, R., Duerinck, J., Neyns, B. & Brock, S., jan. 2026, In: APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 134, 1, 8 blz., e70143.Onderzoeksoutput: Article › peer review
1 Citaat (Scopus) -
Perceptual quality assessment in digital pathology: Modeling diagnostic usability from expert opinions
Nguyen, T., Mahmoudpour, S., Courtoy, G. E., Waelput, W., Forsyth, R., De Vylder, J., Diricx, B., Vandemeulebroucke, J. & Schelkens, P., 1 okt. 2026, In: Computer Methods and Programs in Biomedicine. 285, 15 blz., 109473.Onderzoeksoutput: Article › peer review
-
Calcifying Pseudoneoplasm of the Neuraxis (CAPNON) – Unusual Benign Mass Lesion at the Craniocervical junction of Two Young Patient
Verlinden, L., Forsyth, R., Bruneau, M. & Brock, S., 24 jun. 2025.Onderzoeksoutput: Poster
-
Correction: Debel et al. Does the Choice of Anaesthesia Affect Cancer? A Molecular Crosstalk between Theory and Practice. Cancers 2023, 15, 209.
Debel, W., Ramadhan, A., Vanpeteghem, C. & Forsyth, R. G., 9 sep. 2025, In: Cancers. 17, 18, 4 blz., 2941.Onderzoeksoutput: Article › peer review
Open AccessBestand8 Downloads (Pure) -
Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD1 Immunotherapy
Arnouk, S. M., Kancheva, D., Van Damme, H., Courtoy, G. E., Mora Barthelmess, R., Van Craenenbroeck, J., Lebegge, E., Elkrim, Y., Assaf, N., Heremans, Y., Murgaski, A., De Groof, T. W. M., Clappaert, E., Debraekeleer, A., Brughmans, J., Blancke, G., Kiss, M., Forsyth, R., Waelput, W. & Boon, L. & 9 anderen, , 1 dec. 2025, In: Cancer Research. 85, 23, blz. 4681-4700 20 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand4 Citaten (Scopus)59 Downloads (Pure)
Prijzen
-
Best Oral Presentation Award
Forsyth, R. (Recipient), 20 mei 2006
Prijs: Prize (including medals and awards)
Activiteiten
-
PET/CT imaging with [68Ga]Ga-NOTA-anti-MMR-VHH2 in patients with NSCLC: Interim results of the MAGMA trial
De Mey, L. (Speaker), Bourgeois, S. (Contributor), Bracke, A. (Contributor), Everaert, H. (Contributor), Goethals, L. (Contributor), Gondry, O. (Contributor), Debacker, J. (Contributor), Keyaerts, M. (Contributor), Devoogdt, N. (Contributor), Forsyth, R. (Contributor), Locy, H. (Contributor), Raes, L. (Contributor), Caveliers, V. (Contributor), Van den Block, S. (Contributor), Vaneycken, I. (Contributor), Cousaert, J. (Contributor) & Lahoutte, T. (Contributor)
11 okt. 2024Activiteit: Talk or presentation at a conference
-
PET/CT imaging of high mannose receptor expressing macrophages with [68Ga]Ga-NOTA -Anti-MMR-VHH2: an overview of the clinical results
De Mey, L. (Speaker), Bourgeois, S. (Contributor), Bracke, A. (Contributor), Gondry, O. (Contributor), Everaert, H. (Contributor), Goethals, L. (Contributor), Debacker, J. (Contributor), Keyaerts, M. (Contributor), Devoogdt, N. (Contributor), Raes, L. (Contributor), Caveliers, V. (Contributor), Van den Block, S. (Contributor), Vaneycken, I. (Contributor), Cousaert, J. (Contributor), De Beule, N. (Contributor), Kerselaers, L. A. A. (Contributor), Forsyth, R. (Contributor), Locy, H. (Contributor) & Lahoutte, T. (Contributor)
11 okt. 2024Activiteit: Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W. (Speaker), Schwarze, J. K. (Contributor), Bertels, C. (Contributor), Tijtgat, J. (Contributor), Awada, G. (Contributor), Vaeyens, F. (Contributor), Cras, L. (Contributor), Vanbinst, A. (Contributor), Everaert, H. (Contributor), Michotte, A. (Contributor), Janssen, T. (Contributor), Caljon, B. (Contributor), Cauwenbergh, T. (Contributor), Bruneau, M. (Contributor), Forsyth, R. (Contributor), Tuyaerts, S. (Contributor), Neyns, B. (Contributor) & Duerinck, J. (Contributor)
26 mrt. 2022Activiteit: Talk or presentation at a conference
-
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Geens, W. (Speaker), Schwarze, J. K. (Contributor), Bertels, C. (Contributor), Tijtgat, J. (Contributor), Awada, G. (Contributor), Vaeyens, F. (Contributor), Cras, L. (Contributor), Vanbinst, A. (Contributor), Everaert, H. (Contributor), Michotte, A. (Contributor), Janssen, T. (Contributor), Caljon, B. (Contributor), Cauwenbergh, T. (Contributor), Bruneau, M. (Contributor), Forsyth, R. (Contributor) & Neyns, B. (Contributor)
26 mrt. 2022Activiteit: Talk or presentation at a conference
-
A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA-1)+ / CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Schwarze, J. K. (Presenter), Tijtgat, J. (Contributor), Awada, G. (Contributor), Cras, L. (Contributor), Dufait, I. (Contributor), Forsyth, R. (Contributor), Tuyaerts, S. (Contributor) & Neyns, B. (Contributor)
17 sep. 2021Activiteit: Talk or presentation at a conference